Candel Therapeutics $CADL #enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments from mh drug list Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
⏲ Duration: 11:8 👁 View: 595K times ✓ Published: 19-Jun-2024
Description: Candel Therapeutics, Inc. is helping pioneer the next generation of viral immunotherapy by leveraging a data-driven approach to create new assets and further the development of existing drug candidates.<br/><br/>Candel Therapeutics' enLIGHTEN Discovery Platform integrates artificial intelligence-selected, therapeutic payloads into programmable vectors for delivery into the tumor microenvironment<br/><br/>This tailored approach to discovery and development of new therapeutics has been designed to address the complexity of the tumor microenvironment and the diversity of the tumor response to existing treatments.